The Impact of Exposure Profile on the Efficacy of Dual Amylin and Calcitonin Receptor Agonist Therapy

Background: Dual Amylin and Calcitonin Receptor Agonists (DACRAs) are treatment candidates for obesity and type 2 diabetes. Recently, a once-weekly DACRA (KBP-A) showed promise, potentially due to its different exposure profile compared to daily DACRA (KBP). Parathyroid hormone, a G-protein-coupled...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonne, Nina, Larsen, Anna Thorsø, Karsdal, Morten Asser, Henriksen, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599033/
https://www.ncbi.nlm.nih.gov/pubmed/36289629
http://dx.doi.org/10.3390/biomedicines10102365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599033/
https://www.ncbi.nlm.nih.gov/pubmed/36289629
http://dx.doi.org/10.3390/biomedicines10102365

Ejemplares similares